Literature DB >> 1639156

Plasmodium falciparum: identification and purification of the phosphoglycerate kinase of the malaria parasite.

M Grall1, I K Srivastava, M Schmidt, A M Garcia, J Mauël, L H Perrin.   

Abstract

Multiplication of the human malaria parasite Plasmodium falciparum within red blood cells is an energy-dependent process and glucose consumption increases dramatically in infected red blood cells (IRBC) versus normal red blood cells (NRBC). The major pathway for glucose metabolism in P. falciparum IRBC is anaerobic glycolysis. Phosphoglycerate kinase (PGK) is one of the key enzymes of this pathway as it generates ATP. We found that the PGK specific activity in P. falciparum IRBC is seven times higher than that in NRBC. The parasitic origin of the increase in PGK activity is confirmed by isoelectric focusing. Indeed, two P. falciparum isoenzymes with neutral isoelectric points were detected. P. falciparum PGK in purified form has a molecular mass of 48 kDa. Antiserum raised against purified P. falciparum PGK specifically recognizes the 48-kDa protein band in P. falciparum and also reacts with P. berghei and P. yoelii IRBC lysates but does not cross-react with PGK associated with NRBC.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639156     DOI: 10.1016/0014-4894(92)90117-s

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  2 in total

1.  Phosphoglycerate kinase: structural aspects and functions, with special emphasis on the enzyme from Kinetoplastea.

Authors:  Maura Rojas-Pirela; Diego Andrade-Alviárez; Verónica Rojas; Ulrike Kemmerling; Ana J Cáceres; Paul A Michels; Juan Luis Concepción; Wilfredo Quiñones
Journal:  Open Biol       Date:  2020-11-25       Impact factor: 6.411

2.  Comprehensive proteomics investigation of P. vivax-infected human plasma and parasite isolates.

Authors:  Apoorva Venkatesh; Shalini Aggarwal; Swati Kumar; Srushti Rajyaguru; Vipin Kumar; Sheetal Bankar; Jayanthi Shastri; Swati Patankar; Sanjeeva Srivastava
Journal:  BMC Infect Dis       Date:  2020-03-02       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.